Application of hydrophilic polymers for the preparation of tadalafil solid dispersions: micromeritics properties, release and erectile dysfunction studies in male rats
Mohammed Muqtader Ahmed,
Md Khalid Anwer,
Gamal A. Soliman,
Mohammed F. Aldawsari,
Abdul Aleem Mohammed,
Sultan Alshehri,
Mohammed M. Ghoneim,
Amer S. Alali,
Abdullah Alshetaili,
Ahmed Alalaiwe,
Sarah I. Bukhari,
Ameeduzzafar Zafar
Affiliations
Mohammed Muqtader Ahmed
Pharmaceutics, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia
Md Khalid Anwer
Pharmaceutics, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia
Gamal A. Soliman
Department of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia
Mohammed F. Aldawsari
Pharmaceutics, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia
Abdul Aleem Mohammed
Department of Pharmaceutics, College of Pharmacy, Najran University, Najran, Saudi Arabia
Sultan Alshehri
Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Ad Diriyah, Saudi Arabia
Mohammed M. Ghoneim
Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Ad Diriyah, Saudi Arabia
Amer S. Alali
Pharmaceutics, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia
Abdullah Alshetaili
Pharmaceutics, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia
Ahmed Alalaiwe
Pharmaceutics, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia
Sarah I. Bukhari
Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
Ameeduzzafar Zafar
Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka, Al-Jouf Saudi Arabia
The objective of the present study was to improve the dissolution rate and aphrodisiac activity of tadalafil by using hydrophilic polymers. Solid dispersions were prepared by solvent evaporation-Rota evaporator using Koliphore 188, Kollidon® VA64, and Kollidon® 30 polymers in a 1:1 ratio. Prepared tadalafil-solid dispersions (SDs) evaluated for yield, drug content, micromeritics properties, physicochemical characterizations, and aphrodisiac activity assessment. The optimized SDs TK188 showed size (2.175 ± 0.24 µm), percentage of content (98.89 ± 1.23%), yield (87.27 ± 3.13%), bulk density (0.496 ± 0.005 g/cm3), true density (0.646 ± 0.003 g/cm3), Carr’s index (23.25 ± 0.81), Hausner ratio (1.303 ± 0.003) and angle of repose (<25°). FTIR spectrums revealed tadalafil doesn’t chemically interact with used polymers. XRD and DSC analysis represents TK188 SDs were in the amorphous state. Drug release was 97.17 ± 2.43% for TK188, whereas it was 32.76 ± 2.65% for pure drug at the end of 2 h with 2.96-fold increase in dissolution and followed release kinetics of Korsmeyer Peppa’s model. MDT and DE were noted to be 17.48 minutes and 84.53%, respectively. Furthermore, TK188 SDs showed relative improvement in the sexual behavior of the male rats. Thus the developed SDs TK188 could be potential tadalafil carriers for the treatment of erectile dysfunction.